|
|
Volumn 359, Issue 9320, 2002, Pages 1857-1858
|
|
Effective clinical innovation: An ethical imperative
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ANTILEUKEMIC AGENT;
CEPHALOSPORIN;
LITHIUM;
NEUROLEPTIC AGENT;
PENICILLIN G;
STEROID;
SULFONAMIDE;
CLINICAL STUDY;
DRUG INDUSTRY;
DRUG SCREENING;
FINANCIAL MANAGEMENT;
GOVERNMENT;
HEALTH CARE COST;
HUMAN;
MEDICAL ETHICS;
MEDICAL RESEARCH;
METHODOLOGY;
PRIORITY JOURNAL;
PROCESS CONTROL;
PROFESSIONAL STANDARD;
RISK ASSESSMENT;
SAMPLE SIZE;
SHORT SURVEY;
STANDARD;
TREATMENT OUTCOME;
|
|
EID: 0037172390
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(02)08707-X Document Type: Note |
|
Times cited : (28)
|
|
References (0)
|
